Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes.

Scientific reports - 2 Jun 2016

Qian Xi-Jing, Zhang Xiao-Lian, Zhao Ping, Jin Yong-Sheng, Chen Hai-Sheng, Xu Qing-Qiang, Ren Hao, Zhu Shi-Ying, Tang Hai-Lin, Zhu Yong-Zhe, Qi Zhong-Tian

Abstract excerpt

Despite recent progress in the development of hepatitis C virus (HCV) inhibitors, cost-effective antiviral drugs, especially among the patients receiving liver transplantations, are still awaited. Schisandra is a traditional medicinal herb used to treat a range of liver disorders including hepatitis for thousands of years in China. To isolate the bioactive compounds of schisandra for the treatment of HCV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Synergism
Share to Drugs, Chinese Herbal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatocytes

Share to Interferons

Share to Oligopeptides

Share to Triterpenes

Share to Virus Attachment

Share to Virus Internalization

Source

Open in PubMed Open full text

Identifiers

PMID: 27252043
DOI: 10.1038/srep27268
PMCID: PMC4890123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes.PMID 27252043Read ↗

Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81.Semantic proximity Read ↗

Anti-hepatitis C virus and synergistic potential of Syzgium cumine a bioassay guided screening in liver-infected hepatocytes.Semantic proximity Read ↗

Rational drug discovery: Ellagic acid as a potent dual-target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes.Semantic proximity Read ↗

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D virusesSemantic proximity Read ↗

Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.Semantic proximity Read ↗

Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus , Is a New Inhibitor of Hepatitis C Virus RNA ReplicationSemantic proximity Read ↗

Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus.Semantic proximity Read ↗

Schizandrin A suppressed pancreatic cancer proliferation and cancer associated fibroblast activation via inhibiting the COX-2/ALOX5 shuntingSemantic proximity Read ↗

Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from <i>Juncus maritimus</i> Is a New Inhibitor of Hepatitis C Virus ReplicationSemantic proximity Read ↗

Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection.Semantic proximity Read ↗

Lancemaside A from Codonopsis lanceolata is a broad-spectrum antiviral agent against SARS-CoV-2 and variants of concernSemantic proximity Read ↗

From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.